+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gengnian An Tablets Market - Global Forecast 2026-2032- Product Image
Gengnian An Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Gengnian An Tablets Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128581
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gengnian An Tablets Market is projected to reach USD 214.59 Million in 2026. It is expected to continue growing at a CAGR of 6.25%, reaching USD 302.73 Million by 2032.

Gengnian An Tablets: Executive Summary Scope and Context

Gengnian An Tablets are addressed here as a defined traditional medicine product category. This executive summary focuses on the forces shaping the category, including consumer needs, regulatory expectations, distribution practices, digital engagement, and evidence standards. Because the supplied reference provides no verified quantitative dataset, the discussion is qualitative and avoids unsupported claims about market size, growth, shares, or forecasts.

Regulatory, Consumer, and Channel Shifts Reshaping the Category

The landscape is being transformed by stronger expectations for product quality, ingredient traceability, manufacturing consistency, labeling accuracy, and responsible health communication. Consumers increasingly compare traditional products with other options through digital channels, while pharmacies, clinics, wellness providers, and e-commerce platforms place greater emphasis on documentation and reliable fulfillment. These shifts reward suppliers that can connect traditional-use positioning with transparent evidence, compliant claims, and consistent product experience.

How Artificial Intelligence Can Improve Evidence, Operations, and Engagement

Artificial intelligence can support the category through literature screening, multilingual label review, adverse-event signal detection, demand planning, customer-service triage, and identification of inconsistent product information across channels. Its value depends on governed data, human review, privacy safeguards, and clear separation between educational content and medical advice. AI-generated health claims should not be deployed without qualified regulatory and clinical oversight, particularly where traditional formulations are subject to differing national rules.

Regional Insights Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally requires careful attention to product classification, permitted claims, safety documentation, and channel-specific compliance. Latin America calls for localized labeling, distributor oversight, and sensitivity to varied registration processes. Europe places strong emphasis on harmonized documentation, consumer protection, and distinctions between medicinal, traditional, and food-related positioning. The Middle East requires culturally appropriate communication and country-specific regulatory review, while Africa benefits from robust quality assurance, supply continuity, and locally relevant access models. Asia-Pacific is particularly important for understanding traditional medicine expectations, digital commerce, and diverse national frameworks; no single regional approach should be assumed to apply across all markets.

Group-Level Priorities for ASEAN, BRICS, the European Union, G7, GCC, and NATO

ASEAN requires country-by-country interpretation despite regional cooperation, especially for registration, claims, and import controls. BRICS markets span substantially different regulatory and healthcare environments, making adaptable dossiers and local partnerships important. The European Union benefits from coordinated compliance processes but still requires attention to national implementation and language needs. G7 markets typically demand rigorous quality, safety, and substantiation practices. GCC markets require coordinated regional thinking alongside national requirements, while NATO membership is not a healthcare regulatory framework; analysis involving NATO countries should therefore distinguish defense cooperation from commercial or medical authorization rules.

Country-Level Considerations Across Fifteen Priority Markets

Australia and Canada require clear product classification, compliant claims, and dependable quality documentation. Brazil and Mexico call for Spanish- or Portuguese-language materials, local regulatory expertise, and distributor controls. China, India, Japan, and South Korea require localized approaches to traditional medicine, product registration, evidence, and digital channels. France, Germany, Italy, and Spain require careful alignment with European rules and national market practices. The United Kingdom has a distinct post-EU regulatory context and needs country-specific review. The United States requires particular discipline around labeling, advertising, safety substantiation, and distinctions between supplements and medicines. Russia presents additional considerations involving local rules, logistics, payment channels, and sanctions-related compliance. These observations are directional and should be validated with current authorities before commercialization.

Practical Priorities for Leaders Managing Gengnian An Tablets

Leaders should first establish a country-by-country regulatory matrix covering classification, registration, claims, labeling, pharmacovigilance, imports, and distribution. They should then strengthen supplier qualification, batch traceability, testing protocols, counterfeit detection, and complaint handling. A controlled evidence program should document ingredients, traditional-use rationale, safety information, and any permitted clinical or real-world evidence without overstating conclusions. Finally, organizations should use segmented education for clinicians, pharmacists, consumers, and distributors; monitor digital claims; pilot AI only within documented governance controls; and define measurable quality, compliance, access, and customer-experience indicators.

Research Methodology and Evidence Boundaries

This executive summary uses the supplied product-category reference and the required geographic groupings as the analytical scope. It applies a qualitative framework covering regulation, consumer behavior, channels, technology, operations, and evidence management. No external quantitative assertions were introduced, and no market estimates, shares, sizing, forecasts, or company-specific comparisons are included. Country and regional observations are high-level hypotheses for executive planning and require validation against current legislation, official guidance, pharmacovigilance requirements, import rules, and primary stakeholder research.

Conclusion: Build Trust Through Compliance, Evidence, and Local Relevance

The strongest foundation for Gengnian An Tablets is disciplined execution rather than unsupported scale claims. Success depends on consistent quality, transparent communication, defensible evidence, localized regulatory strategy, and reliable access across diverse channels and jurisdictions. Organizations that combine traditional-product knowledge with modern data governance, responsible AI, and market-specific compliance will be better positioned to earn confidence from consumers, healthcare intermediaries, regulators, and distribution partners.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gengnian An Tablets Market, by Product Type
7.1. Introduction
7.2. Original Branded Gengnian An
7.2.1. Standard Formula
7.2.2. Enhanced Or Modified Formula
7.3. Generic Equivalent
7.3.1. Regulated Generic Products
7.3.2. Hospital-Compounded Equivalents
7.4. Combination Regimen Product
7.4.1. Co-Packaged With Hormone Therapy
7.4.2. Co-Packaged With Other TCM Formulas
7.5. Special Formulation Variant
7.5.1. Sugar-Free Tablets
7.5.2. Coated Tablets
7.5.3. Extended-Release Tablets
8. Gengnian An Tablets Market, by Indication
8.1. Introduction
8.2. Irregular Menstruation
8.3. Menopause Syndrome
9. Gengnian An Tablets Market, by Dosage Strength
9.1. Introduction
9.2. 0.6 G
9.3. 1.2 G
10. Gengnian An Tablets Market, by Coating Type
10.1. Introduction
10.2. Film-Coated
10.3. Uncoated
11. Gengnian An Tablets Market, by Sales Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Gengnian An Tablets Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Gengnian An Tablets Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Gengnian An Tablets Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Anhui Kangle Pharmaceutical Co., Ltd.
16.2. Beijing Tong Ren Tang Co., Ltd.
16.3. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
16.4. Guangzhou Pharmaceutical Holdings Limited
16.5. Harbin Pharmaceutical Group Co., Ltd.
16.6. Jiangsu Kanion Pharmaceutical Co., Ltd.
16.7. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
16.8. Tianjin Tasly Pharmaceutical Co., Ltd.
16.9. Yunnan Baiyao Group Co., Ltd.
16.10. Zhejiang Kanghua Pharmaceutical Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gengnian An Tablets Market, Years Considered for the Study
FIGURE 2. Global Gengnian An Tablets Market, Research Design
FIGURE 3. Global Gengnian An Tablets Market, Research Framework
FIGURE 4. Global Gengnian An Tablets Market, Data Triangulation
FIGURE 5. Global Gengnian An Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gengnian An Tablets Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Gengnian An Tablets Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gengnian An Tablets Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Gengnian An Tablets Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gengnian An Tablets Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 11. Global Gengnian An Tablets Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gengnian An Tablets Market Size, by Coating Type, 2025 vs 2032 (%)
FIGURE 13. Global Gengnian An Tablets Market Size, by Coating Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gengnian An Tablets Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 15. Global Gengnian An Tablets Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gengnian An Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Gengnian An Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Gengnian An Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gengnian An Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Gengnian An Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Gengnian An Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gengnian An Tablets Market Segmentation & Coverage
TABLE 2. Global Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Original Branded Gengnian An Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Original Branded Gengnian An Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Original Branded Gengnian An Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Standard Formula Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Standard Formula Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Standard Formula Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Enhanced Or Modified Formula Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Enhanced Or Modified Formula Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Enhanced Or Modified Formula Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Generic Equivalent Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Generic Equivalent Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Generic Equivalent Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Regulated Generic Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Regulated Generic Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Regulated Generic Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Hospital-Compounded Equivalents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Hospital-Compounded Equivalents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Hospital-Compounded Equivalents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Combination Regimen Product Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Combination Regimen Product Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Combination Regimen Product Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Co-Packaged With Hormone Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Co-Packaged With Hormone Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Co-Packaged With Hormone Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Co-Packaged With Other TCM Formulas Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Co-Packaged With Other TCM Formulas Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Co-Packaged With Other TCM Formulas Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Special Formulation Variant Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Special Formulation Variant Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Special Formulation Variant Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Sugar-Free Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Sugar-Free Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Sugar-Free Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Coated Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Extended-Release Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 44. Global Irregular Menstruation Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Irregular Menstruation Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Irregular Menstruation Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Menopause Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Menopause Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Menopause Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 51. Global 0.6 G Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global 0.6 G Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global 0.6 G Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global 1.2 G Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global 1.2 G Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global 1.2 G Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 58. Global Film-Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Film-Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Film-Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Uncoated Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Uncoated Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Uncoated Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 65. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 85. North America Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. North America Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. North America Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 88. North America Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 89. North America Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 90. North America Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 91. North America Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 92. North America Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 93. North America Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 94. North America Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 95. Latin America Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Latin America Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Latin America Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 98. Latin America Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 99. Latin America Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 100. Latin America Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 101. Latin America Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 102. Latin America Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 103. Latin America Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 104. Latin America Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 105. Europe Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Europe Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Europe Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 108. Europe Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 109. Europe Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 110. Europe Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 111. Europe Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 112. Europe Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 113. Europe Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 114. Europe Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 115. Middle East Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Middle East Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Middle East Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 118. Middle East Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 119. Middle East Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 120. Middle East Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 121. Middle East Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 122. Middle East Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 123. Middle East Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 124. Middle East Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 125. Africa Gengnian An Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Africa Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. Africa Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 128. Africa Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 129. Africa Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 130. Africa Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 131. Africa Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. Africa Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 133. Africa Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 134. Africa Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 135. Global Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. ASEAN Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 139. ASEAN Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 140. ASEAN Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 141. ASEAN Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 142. ASEAN Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 143. ASEAN Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 144. ASEAN Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 145. ASEAN Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 146. GCC Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. GCC Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. GCC Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 149. GCC Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 150. GCC Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 151. GCC Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 152. GCC Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 153. GCC Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 154. GCC Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 155. GCC Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 156. European Union Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. European Union Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. European Union Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 159. European Union Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 160. European Union Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 161. European Union Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 162. European Union Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 163. European Union Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 164. European Union Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 165. European Union Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 166. BRICS Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. BRICS Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. BRICS Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 169. BRICS Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 170. BRICS Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 171. BRICS Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 172. BRICS Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. BRICS Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 174. BRICS Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 175. BRICS Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 176. G7 Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. G7 Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. G7 Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 179. G7 Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 180. G7 Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 181. G7 Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 182. G7 Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 183. G7 Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 184. G7 Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 185. G7 Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 186. NATO Gengnian An Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. NATO Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. NATO Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 189. NATO Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 190. NATO Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 191. NATO Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 192. NATO Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. NATO Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 194. NATO Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 195. NATO Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 196. Global Gengnian An Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 197. United States Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 198. United States Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. United States Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 200. United States Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 201. United States Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 202. United States Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 203. United States Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 204. United States Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 205. United States Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 206. United States Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 207. Canada Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 208. Canada Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Canada Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 210. Canada Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 211. Canada Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 212. Canada Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 213. Canada Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. Canada Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 215. Canada Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 216. Canada Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 217. Mexico Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 218. Mexico Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Mexico Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 220. Mexico Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 221. Mexico Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 222. Mexico Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 223. Mexico Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 224. Mexico Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 225. Mexico Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 226. Mexico Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 227. Brazil Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 228. Brazil Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Brazil Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 230. Brazil Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 231. Brazil Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 232. Brazil Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 233. Brazil Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 234. Brazil Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 235. Brazil Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 236. Brazil Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 237. United Kingdom Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 238. United Kingdom Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. United Kingdom Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 240. United Kingdom Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 241. United Kingdom Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 242. United Kingdom Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 243. United Kingdom Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 244. United Kingdom Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 245. United Kingdom Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 246. United Kingdom Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 247. Germany Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 248. Germany Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. Germany Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 250. Germany Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 251. Germany Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 252. Germany Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 253. Germany Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 254. Germany Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 255. Germany Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 256. Germany Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 257. France Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 258. France Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. France Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 260. France Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 261. France Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 262. France Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 263. France Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 264. France Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 265. France Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 266. France Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 267. Russia Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 268. Russia Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. Russia Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 270. Russia Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 271. Russia Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 272. Russia Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 273. Russia Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 274. Russia Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 275. Russia Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 276. Russia Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 277. Italy Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 278. Italy Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. Italy Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 280. Italy Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 281. Italy Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 282. Italy Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 283. Italy Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 284. Italy Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 285. Italy Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 286. Italy Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 287. Spain Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 288. Spain Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. Spain Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 290. Spain Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 291. Spain Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 292. Spain Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 293. Spain Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 294. Spain Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 295. Spain Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 296. Spain Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 297. China Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 298. China Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. China Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 300. China Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 301. China Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 302. China Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 303. China Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 304. China Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 305. China Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 306. China Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 307. India Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 308. India Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. India Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 310. India Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 311. India Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 312. India Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 313. India Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 314. India Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 315. India Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 316. India Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 317. Japan Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 318. Japan Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. Japan Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 320. Japan Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 321. Japan Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 322. Japan Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 323. Japan Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 324. Japan Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 325. Japan Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 326. Japan Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 327. Australia Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 328. Australia Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 329. Australia Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 330. Australia Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 331. Australia Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 332. Australia Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 333. Australia Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 334. Australia Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 335. Australia Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD Million)
TABLE 336. Australia Gengnian An Tablets Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 337. South Korea Gengnian An Tablets Market Size, 2017-2032 (USD Million)
TABLE 338. South Korea Gengnian An Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. South Korea Gengnian An Tablets Market Size, by Original Branded Gengnian An, 2017-2032 (USD Million)
TABLE 340. South Korea Gengnian An Tablets Market Size, by Generic Equivalent, 2017-2032 (USD Million)
TABLE 341. South Korea Gengnian An Tablets Market Size, by Combination Regimen Product, 2017-2032 (USD Million)
TABLE 342. South Korea Gengnian An Tablets Market Size, by Special Formulation Variant, 2017-2032 (USD Million)
TABLE 343. South Korea Gengnian An Tablets Market Size, by Indication, 2017-2032 (USD Million)
TABLE 344. South Korea Gengnian An Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 345. South Korea Gengnian An Tablets Market Size, by Coating Type, 2017-2032 (USD

Companies Mentioned

  • Anhui Kangle Pharmaceutical Co., Ltd.
  • Beijing Tong Ren Tang Co., Ltd.
  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
  • Guangzhou Pharmaceutical Holdings Limited
  • Harbin Pharmaceutical Group Co., Ltd.
  • Jiangsu Kanion Pharmaceutical Co., Ltd.
  • Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  • Tianjin Tasly Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Zhejiang Kanghua Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast 2026-2032 - Product Image

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Macitentan Tablets Market - Global Forecast 2026-2032 - Product Image

Macitentan Tablets Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Detachable Tablets - Global Strategic Business Report - Product Image

Detachable Tablets - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Enterprise Tablets - Global Strategic Business Report - Product Image

Enterprise Tablets - Global Strategic Business Report

  • Report
  • 175 Pages
  • Global
From
Isosorbide Mononitrate Tablet Market Report 2026 - Product Image

Isosorbide Mononitrate Tablet Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.